For an update on diabetic kidney disease and a short discussion of empagliflozen take a look at this lecture I gave a few weeks ago.
#NephJC on AKI timing: some comparisons
Next #NephJC: Timing of renal replacement therapy in AKI
Next week, on May 31 in American and June 1 in Europe, we will be discussing the two major AKI studies looking at the timing of renal replacement therapy:
Look for a formal background post later this week.
Stop the presses!
Landmark trial dropped in the NEJM yesterday. We will be covering AKIKI on May 31 and June 1 instead of the Pip/Tazo trial. Sorry for the change in plans. We will reschedule Pip/Tazo and AKI, probably for the first week in July, but with ERA-EDTA approaching who knows?
Additional acetazolamide data
CV Risk scores: homework for #NephJC
Some SPLIT spin from PBFluids
Joel Topf wrote a bit about one of the primary criticisms of the SPLIT trial at PBFluids. Take a look.
Why is normal saline acidic?
Interesting twitter sleuthing last week. Includes letter to and response from the author of the recent NEJM review of maintenance fluids. Being familiar with this will come in hand during the SPLIT chat on Tuesday and Wednesday.
The First NephJC Google Hangout
We are interested in finding innovative ways to share the collective wisdom of the nephrology community. The Twitter discussions have been excellent so far. Our next experiment is a Google Hangout, which is a video chat. The idea is that we will present a new journal article on alternating Tuesdays. Then on the off Tuesday we will broadcast a Google Hangout which will summarize the previous week's Twitter Chat and introduce the next week's journal club article. This will provide a tick-tock rhythm to NephJC.
We are new to Google Hangouts so we will be experimenting with various formats. For the first one we will have one of the article's authors, Vlado Perkovic join Joel Topf, Paul Phelan and Hiremath Swapnil on the Hangout. We will take audience questions during the hangout.
Each hangout will be recorded and added to commentary on the article.
